A carregar...
Psoriasis Induced by Trastuzumab (Herceptin®)
Trastuzumab (Herceptin), a humanized monoclonal antibody, is a cancer drug developed to target the human epidermal receptor (HER) 2, which is overexpressed in some cancer cells. Cutaneous side effects, such as folliculitis, xerosis, and alopecia have not been reported with therapies targeting HER2,...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Korean Dermatological Association; The Korean Society for Investigative Dermatology
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3662920/ https://ncbi.nlm.nih.gov/pubmed/23717018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5021/ad.2013.25.2.229 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|